Pradaxa 50 mg overtrukket granulat; forsyningsvanskelighed
Safety Classified by Officially
Markedsføringen af Pradaxa 50 mg overtrukket granulat fra Boehringer Ingelheim Danmark A/S vil ophøre.
Produkt: Pradaxa 50 mg overtrukket granulat
Aktivt stof: Dabigatranetexilat (Dabigatranetexilatmesilat)
Forventet periode: Fra slut november 2026
Virksomhed: Boehringer Ingelheim Danmark A/S
Yderligere information: Permanent markedsophør
This is an extract. The publication continues at the source.
Source: Lægemiddelstyrelsen.
Read the original at the source: https://laegemiddelstyrelsen.dk/da/godkendelse/kontrol-og-inspektion/mangel-paa-medicin/meddelelser-om-forsyning-af-medicin/human-2026/pradaxa-50-mg-overtrukket-granulat-forsyningsvanskelighed/
Officially imported this from Lægemiddelstyrelsen’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Lægemiddelstyrelsen — imported from official source
- Official source
- https://laegemiddelstyrelsen.dk/da/Feeds/rss-feed/ RSS
- Imported
- October 03, 2026 20:38
- Versions
- 1 recorded
- Identity
-
DB8D93542B2A4A7FA832848F53779B8A